Incruse Ellipta
My Prescription
Payment
Select pharmacy
$315.61
$15.00 due at pharmacy
$315.61 - $15.00 = $300.61
$300.61 remaining balance
You will be given your coupon after you complete your purchase with PayPal.
WalmartPowered by$315.61
Print or send this coupon to your phone
WalmartPowered byAbout Incruse Ellipta
Drug Details
Umeclidinium, marketed as Incruse Ellipta, is an inhaled medication primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults. This includes conditions such as chronic bronchitis and emphysema. Umeclidinium belongs to a class of drugs known as long-acting muscarinic antagonists (LAMA), which are a type of anticholinergic. It functions by blocking the chemical acetylcholine, which helps relax the muscles around the airways, making breathing easier. By effectively controlling COPD symptoms like wheezing and shortness of breath, umeclidinium can help reduce disruptions to daily activities such as work or school. It is important to use this medication regularly as prescribed, as it does not provide immediate relief for sudden breathing difficulties. In such cases, a quick-relief inhaler should be used. Common side effects may include symptoms similar to a cold, such as a sore throat and cough. Always consult healthcare professionals before starting or changing any medication regimen.
Price history for Incruse Ellipta
30 Aerosol Powder Breath Activateds, 62.5MCG/ACT
Average retail price for Incruse Ellipta
Average SaveHealth price for Incruse Ellipta
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Incruse Ellipta dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 62.5MCG/ACT | 30 Aerosol Powder Breath Activateds | $315.61 | $10.52 |
| 62.5MCG/ACT | 7 Aerosol Powder Breath Activateds | $77.48 | $11.07 |
Incruse Ellipta FAQs
Incruse Ellipta is not a steroid inhaler. It is a long-acting muscarinic antagonist (LAMA) used for the maintenance treatment of chronic obstructive pulmonary disease (COPD).
Incruse Ellipta is typically used for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in patients with moderate to severe stages. It is not intended for the relief of acute bronchospasm or as a rescue inhaler.
A potential cheaper alternative to Incruse Ellipta (umeclidinium) could be tiotropium, commonly known by the brand name Spiriva. However, it is important for the patient to consult with their healthcare provider to determine the most appropriate and cost-effective option for their specific condition.
Yes, the generic name for Incruse is umeclidinium.
Incruse Ellipta should not be used by individuals who have a severe allergy to umeclidinium or any of the ingredients in the medication. It is also not recommended for people with severe hypersensitivity to milk proteins, as the inhaler contains lactose. Additionally, it should be used with caution in patients with narrow-angle glaucoma, urinary retention, or severe liver impairment. It is important for patients to consult with their healthcare provider to determine if Incruse Ellipta is appropriate for their condition.